As the world’s pharmaceutical industry continues to see an influx of consolidation, reports say the latest merger was announced when Merck and Idenix Pharmaceuticals revealed plans to combine in a $3.85 billion deal.
According to a press release, the transaction has already been approved by the boards of directors for both …read more
Source: Global Competition Law Blogs